bharat biotech
- Health
Bharat Biotech to collaborate with Alopexx for broad-spectrum antimicrobial vaccine AV0328
Hyderabad: Bharat Biotech announced a collaboration with Alopexx, Inc., for the co-development and commercialization of Alopexx’s proprietary broad-spectrum antimicrobial vaccine, AV0328, in India.The vaccine will be made available in other low and…
- Hyderabad
Hyderabad: Vice President Jagdeep Dhankhar visits Bharat Biotech
Hyderabad: Vice President Jagdeep Dhankhar on Friday visited Bharat Biotech, which is focused on innovation, research & development, and large-scale manufacturing facilities for vaccines. Accompanied by Telangana Governor C.P. Radhakrishnan, the Vice…
- Featured News
India to launch trials on new TB vaccine; Hyderabad firm Bharat Biotech takes lead
TB or Tuberculosis, the once dreaded disease, continues to remain a top killer in India. BCG, the only available vaccine is over a hundred years old. The multi-drug therapy, though quite effective…
- Hyderabad
Hyderabad: Bharat Biotech begins clinical trials of TB vaccine on adults
Hyderabad: Bharat Biotech International Ltd on Sunday said it started clinical trials of the Tuberculosis vaccine Mtbvac on adults in India. This is the first vaccine against Tuberculosis derived from a human…
- Hyderabad
Hyderabad-based Bharat Biotech, Sydney Uni to advance vaccine research
Hyderabad: Leading vaccine-maker Bharat Biotech and the University of Sydney Infectious Diseases Institute (Sydney ID) on Tuesday announced a Memorandum of Understanding (MoU) to advance vaccine research initiatives, strengthen academic-industry partnerships and…
- Featured News
Bharat Biotech, University of Sydney sign MoU to advance vaccine research collaboration
Hyderabad: Bharat Biotech International Limited, a world leading vaccines & bio-therapeutics manufacturer and the University of Sydney Infectious Diseases Institute (Sydney ID) today (Tuesday) announced signing of a Memorandum of Understanding (MoU) to advance…
- Hyderabad
3 lakh doses of intranasal Covid vaccine sent to hospitals: Bharat Biotech’s Krishna Ella
New Delhi: Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company’s executive chairman Krishna Ella said on Sunday. He was speaking on…
- Delhi
India’s first intranasal COVID-19 vaccine iNNCOVACC launched
New Delhi: Union Health Minister Mansukh Mandaviya on Thursday unveiled the COVID-19 vaccine, iNNCOVACC in the presence of Union Minister of State (IC) for Science and Technology, Jitendra Singh. iNNCOVACC is the…
- Telangana
MNCs are leveraging Telangana’s technology, life sciences ecosystem: KTR at Davos
Hyderabad: Telangana Industries minister K T Rama Rao (KTR) on Thursday said that global companies are leveraging Telangana’s Technology and life science ecosystem. The minister made the statement during a panel discussion…
- Hyderabad
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
Hyderabad: Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. According…
- Hyderabad
Bharat Biotech’s intranasal COVID-19 vaccine priced at Rs 800
Hyderabad: Vaccine maker Bharat Biotech’s intranasal vaccine for COVID-19, the first in the world, is scheduled to be introduced in the country as a booster dose shortly. The vaccine, iNCOVACC (BBV154), is…
- India
Bharat Biotech’s intranasal COVID vaccine approved by govt, to be available on CO-WIN
New Delhi: Bharat Biotech’s intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in the vaccination programme as a booster dose for those above 18 years of age,…
- Hyderabad
Controversies continue to dog India’s 1st indigenous COVID-19 vax
Hyderabad: Covaxin, India’s first indigenous vaccine for Covid-19, was recently hit by a row with allegations that external pressure to deliver the jab quickly forced vaccine-maker Bharat Biotech to skin certain processes…
- India
World’s 1st Intranasal Covid vax from Bharat Biotech gets CDSCO approval
Hyderabad: Leading vaccine maker, Bharat Biotech International Limited (BBIL) on Monday announced that world’s first intranasal vaccine for Covid-19, iNCOVACC (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO)…
- Bangalore
Bharat Biotech evinces interest to invest in Karnataka
Bengaluru: Covaxin maker Dr. Krishna M. Ella has evinced interest in investing in Karnataka. Ella, Chairman and MD of Bharat Biotech, which produces Covaxin, met state Minister for Large and Medium Industries…
